# Evelo Biosciences, Inc. — Form D/A

Evelo Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-02-12. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-02-12
- Form: D/A
- Accession: 0001140361-18-006578
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 11
- Date of first sale: 2017-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278687

## Issuer

- Name: Evelo Biosciences, Inc.
- CIK: 0001694665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 620 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 617 870 8281

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| Noubar B Afeyan, Ph.D. | Director | Cambridge, MA |
| William P DeVaul | Executive Officer | Waltham, MA |
| David R Epstein | Director | Cambridge, MA |
| DAVID A BERRY, M.D., PH.D. | Director | CAMBRIDGE, MA |
| Jennifer P Glennon | Executive Officer | Cambridge, MA |
| Balkrishan (Simba) B Gill, Ph.D. | Director | Cambridge, MA |
| Balkrishan (Simba) B Gill, Ph.D. | Executive Officer | Cambridge, MA |
| Lord Ara P Darzi | Director | Cambridge, MA |
| Duncan P McHale | Executive Officer | Cambridge, MA |
| David P Perry | Director | Cambridge, MA |
| Mark P Bodmer, Ph.D. | Executive Officer | Cambridge, MA |
| Theodose B Melas-Kyriazi | Director | Cambridge, MA |
| Theodose A Melas-Kyriazi | Director | Cambridge, MA |
| Balkrishan (Simba) A Gill, Ph.D. | Director | Cambridge, MA |
| Balkrishan (Simba) A Gill, Ph.D. | Executive Officer | Cambridge, MA |
| Jackie P Papkoff | Executive Officer | Cambridge, MA |
| Derek P Adams | Executive Officer | Cambridge, MA |
| Mark A Pruzanski | Director | Cambridge, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-03-23](https://search.stillhousedata.com/formd/0001140361-18-014827) | D/A | $81.5M | $81.5M |
| [2018-02-20](https://search.stillhousedata.com/formd/0001140361-18-009134) | D | $47.5M | $47.5M |
| [2017-01-18](https://search.stillhousedata.com/formd/0001140361-17-002107) | D | $30.5M | $30.5M |

## More

- [CIK 1694665 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1694665&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-18-006578.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.